Literature DB >> 19881515

Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy.

Alessandro Antonelli1, Clodoveo Ferri, Poupak Fallahi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19881515     DOI： 10.1038/nrgastro.2009.168

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  12 in total

1.  Pegylated interferon-alpha2beta in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-alpha2beta in a hepatitis C population: meta-analysis.

Authors:  Huy A Tran; John R Attia; Tracey L Jones; Robert G Batey
Journal:  J Gastroenterol Hepatol       Date:  2007-04       Impact factor: 4.029

Review 2.  Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis.

Authors:  J A Yalowitz; H N Jayaram
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

Review 3.  Endocrine manifestations of hepatitis C virus infection.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Michele Colaci; Domenico Sansonno; Poupak Fallahi
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

Review 4.  Interferon-alpha and autoimmune thyroid disease.

Authors:  Mark F Prummel; Peter Laurberg
Journal:  Thyroid       Date:  2003-06       Impact factor: 6.568

5.  Interferon-induced thyroid dysfunction in chronic hepatitis C.

Authors:  Khaleel M Jamil; Peter J Leedman; Nickolas Kontorinis; Lorenzo Tarquinio; Saroja Nazareth; Marion McInerney; Crystal Connelly; James Flexman; Valerie Burke; Cecily Metcalf; Wendy Cheng
Journal:  J Gastroenterol Hepatol       Date:  2009-12-01       Impact factor: 4.029

6.  Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.

Authors:  Thomas P Giordano; Louise Henderson; Ola Landgren; Elizabeth Y Chiao; Jennifer R Kramer; Hashem El-Serag; Eric A Engels
Journal:  JAMA       Date:  2007-05-09       Impact factor: 56.272

7.  Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?

Authors:  Elena Vezali; Ioannis Elefsiniotis; Constantinos Mihas; Evangelos Konstantinou; George Saroglou
Journal:  J Gastroenterol Hepatol       Date:  2009-03-11       Impact factor: 4.029

8.  The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses.

Authors:  C Hultgren; D R Milich; O Weiland; M Sällberg
Journal:  J Gen Virol       Date:  1998-10       Impact factor: 3.891

9.  Thyroid disorders in chronic hepatitis C.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Alessandro Pampana; Poupak Fallahi; Claudia Nesti; Martina Pasquini; Santino Marchi; Ele Ferrannini
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

10.  Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.

Authors:  L Fernandez-Soto; A Gonzalez; F Escobar-Jimenez; R Vazquez; E Ocete; N Olea; J Salmeron
Journal:  Arch Intern Med       Date:  1998-07-13
View more
  13 in total

Review 1.  Thyroid Autoimmunity and Function after Treatment with Biological Antirheumatic Agents in Rheumatoid Arthritis.

Authors:  Sofie Bliddal; Stina Willemoes Borresen; Ulla Feldt-Rasmussen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

2.  High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy.

Authors:  Rasha Eletreby; Mohamed Said; Zeinab Abdellatif; Yasmin Saad; Magdy ElSerafy; Hosam Dabes; Kadry ElSaeed; Yehia El-Shazly; Wahid Doss
Journal:  Hepatol Int       Date:  2018-02-14       Impact factor: 6.047

Review 3.  Environmental triggers of thyroiditis: hepatitis C and interferon-α.

Authors:  F Menconi; A Hasham; Y Tomer
Journal:  J Endocrinol Invest       Date:  2010-02-28       Impact factor: 4.256

4.  Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.

Authors:  Jennifer S Mammen; Sharon R Ghazarian; Antony Rosen; Paul W Ladenson
Journal:  Thyroid       Date:  2013-08-03       Impact factor: 6.568

Review 5.  Cytokines and HCV-related disorders.

Authors:  Poupak Fallahi; Clodoveo Ferri; Silvia Martina Ferrari; Alda Corrado; Domenico Sansonno; Alessandro Antonelli
Journal:  Clin Dev Immunol       Date:  2012-05-07

6.  Association of interferon-alpha and ribavirin-induced thyroid dysfunction with severity of disease and response to treatment in pakistani asian patients of chronic hepatitis C.

Authors:  Amina Nadeem; Muhammad Aslam
Journal:  Hepat Res Treat       Date:  2012-09-02

7.  The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study.

Authors:  Huy A Tran; Tracey L Jones; Elizabeth A Ianna; Glenn Em Reeves
Journal:  Thyroid Res       Date:  2011-01-08

Review 8.  Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Ugo Politti; Dilia Giuggioli; Clodoveo Ferri; Alessandro Antonelli
Journal:  Int J Endocrinol       Date:  2014-10-13       Impact factor: 3.257

9.  Thyroid dysfunction in chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors.

Authors:  Zehui Yan; Ke Fan; Yi Fan; Xiaohong Wang; Qing Mao; Guohong Deng; Yuming Wang
Journal:  Hepat Mon       Date:  2012-09-30       Impact factor: 0.660

10.  Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.

Authors:  Yong Hwang; Won Kim; So Young Kwon; Hyung Min Yu; Jeong Han Kim; Won Hyeok Choe
Journal:  Korean J Intern Med       Date:  2015-10-30       Impact factor: 2.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.